In 2022, Tianjin Pharmaceutical Holdings Co., Ltd. (Tianjin Pharma) took Tianjin Jinyao Group Co., Ltd. as the main body to build Tianjin Pharma’s asset and investment management platform to further smooth out the asset relationship and integrate the non-main business enterprises within Tianjin Pharma’s system, thus to lay a good foundation for future capital operation. Tianjin Jinyao Group Co., Ltd. completed the change of corporate juridical person on March 30, 2022, and officially changed its name to Jinyao Asset Management Co., Ltd.

Jinyao Asset Management Co., Ltd. is a wholly-owned subsidiary of Tianjin Pharma. Its business functions are mainly related to the investment management and property operation of Tianjin Pharma. Its business objective is to enhance management efficiency and profitability through specialized and efficient investment, operation, management and related professional services, actively serve Tianjin Pharma’s investment strategy, make every effort to revitalize idle properties, promote property operation, maximize the appreciation of the assets and the investment income, and bring returns to the shareholders.